DrugPatentWatch Database Preview
Drugs in Development Information for Fluoropyrimidine
Email this page to a colleague
What is the development status for investigational drug Fluoropyrimidine?
Fluoropyrimidine is an investigational drug.
There have been 244 clinical trials for Fluoropyrimidine.
The most recent clinical trial was a Phase 3 trial, which was initiated on May 5th 2019.
The most common disease conditions in clinical trials are Colorectal Neoplasms, Stomach Neoplasms, and Adenocarcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), Hoffmann-La Roche, and Eli Lilly and Company.
There are eight hundred and ninety-nine US patents protecting this investigational drug and eight international patents.
Summary for Fluoropyrimidine
| US Patents | 899 |
| International Patents | 8,346 |
| US Patent Applications | 2,778 |
| WIPO Patent Applications | 1,488 |
| Japanese Patent Applications | 951 |
| Clinical Trial Progress | Phase 3 (2019-05-05) |
| Vendors | 68 |
Recent Clinical Trials for Fluoropyrimidine
| Title | Sponsor | Phase |
|---|---|---|
| A Study of the Safety and PK of PCS6422 (Eniluracil) With Capecitabine in Patients With Advanced, Refractory GI Tract Tumors | Processa Pharmaceuticals | Phase 1 |
| A Study of RO7121661 and RO7247669 Compared With Nivolumab in Participants With Advanced or Metastatic Squamous Cell Carcinoma of the Esophagus | Hoffmann-La Roche | Phase 2 |
| Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma | Hallym University Medical Center | Phase 1/Phase 2 |
Clinical Trial Summary for Fluoropyrimidine
Top disease conditions for Fluoropyrimidine
Top clinical trial sponsors for Fluoropyrimidine
US Patents for Fluoropyrimidine
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Fluoropyrimidine | Try Before You Buy | Lin28/let-7 crystal structures, purification protocols, and molecular probes suitable for screening assays and therapeutics | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (Cambridge, MA) | Try Before You Buy |
| Fluoropyrimidine | Try Before You Buy | Combination therapies for cancer | MERCK SHARP & DOHME CORP. (Rahway, NJ) NOVARTIS AG (Basel, CH) | Try Before You Buy |
| Fluoropyrimidine | Try Before You Buy | Tapered looped suture | Covidien LP (Mansfield, MA) | Try Before You Buy |
| Fluoropyrimidine | Try Before You Buy | Methods of enhancing antibody-dependent cellular cytotoxicity | VentiRx Pharmaceuticals, Inc. (Seattle, WA) | Try Before You Buy |
| Fluoropyrimidine | Try Before You Buy | Dosing regimens for echinocandin class compounds | Cidara Therapeutics, Inc. (San Diego, CA) | Try Before You Buy |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Fluoropyrimidine
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Fluoropyrimidine | World Intellectual Property Organization (WIPO) | WO2013071079 | 2031-11-09 | Try Before You Buy |
| Fluoropyrimidine | European Patent Office | EP3003316 | 2033-05-31 | Try Before You Buy |
| Fluoropyrimidine | Hong Kong | HK1223552 | 2033-05-31 | Try Before You Buy |
| Fluoropyrimidine | Japan | JP2016524618 | 2033-05-31 | Try Before You Buy |
| Fluoropyrimidine | Japan | JP6720075 | 2033-05-31 | Try Before You Buy |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
